Arguments Enterd:
mode:mode2,
resDir:/prod/www/nslab/NOD/Results/SC_Zika_polypro_results_0.626/,
tblDir:Results/SC_Zika_polypro_results_0.626,
jobId:SC_Zika_polypro

Content-type:text/html



<!DOCTYPE html>
	<html lang="en">
		<head>
	<meta charset="utf-8">
	<meta content="width=device-width, initial-scale=1.0" name="viewport">
<!--TABLE STYLING-->
<style>
table {
  border-spacing:5px;
  width: 100%;
  padding: 5px;
  border-collapse: collapse;
}

th, td {
  padding: 10px;
  text-align:center;
  border-bottom: 1px solid #ddd;
  border-collapse: collapse;
}

tr:hover {background-color:#f5f5f5;}
</style>

	<title>NOD-New use of Old Drugs</title>
	<meta content="" name="description">
	<meta content="" name="keywords">

  <!-- Favicons -->
  <link href="../../NOD/img/NOD_img2.png" rel="icon">


  <!-- Google Fonts -->
  <!--  Main CSS File -->
  <link href="../../NOD/css/style.css" rel="stylesheet">

  <!-- =======================================================
  *Name: WS-NOD - v 1.2.0
  *Author: Tarun Jairaj Narwani
  *License: Creative Commons
  ======================================================== -->
</head>

<body>
<!-- ======= Header ======= -->
<header>
    <div id="header" class="container">
        <div>
        <h1 class="logo"><a href="../../NOD/index.html"><img src="../../NOD/img/icons/NOD_logo.png" height="60px" width="180px"></a></h1>
        </div>
        <div>
        <nav>
          <ul>
            <li><a href="../../NOD/index.html">Home</a></li>
            <li><a href="../../NOD/webpages/about.html">About-NOD</a></li>
            <li><a href="../../NOD/webpages/instructions.html">Instructions</a></li>
            <li class="active"><a href="../../NOD/webpages/run.html">Run-Options</a></li>
            <!--<li><a href="../../NOD/webpages/organisms.html">Model Organisms</a></li>-->
			<li><a href="../../NOD/webpages/faq.html">F.A.Q</a></li>
            <li><a href="../../NOD/webpages/team.html">The Team</a></li>
            <li><a href="../../NOD/webpages/contact.html">Contact</a></li>
  
          </ul>
        </nav><!-- .nav-menu -->
        </div>
      </div>
</header>
<!-- ======= Tables Section ======= -->
	<div id="noheader" class="noheader section-bg">
        <div id="results" class="section-title">
        <h2> Results for the Job Title: SC_Zika_polypro </h2>
        <div style="text-align: center"><p>The following table consists of potential drug candidates against your query protein(s).<br><br><i>Any drug that has been approved at least once in the past is included.<br>The essential information that might be helpful to make a decision are presented in the table.</i><br></p></div>
		<h5> Instructions to understand the result table organization.</h5>
        </div>

		<div class="container">
        
        <table id="resDisplay" style="border: 1px solid black">
			<thead>
            <tr><i>Results for Query protein entered</i></tr>
            <tr>
            <th>Target homolog</th>
            <th>Query Coverage</th>
            <th>Alignment Start</th>
            <th>Alignment End</th>
            <th>1&deg;Candidate</th>
			<th>Molecule Name</th>
			<th>Regulatory Status</th>
            <th>2&deg;Candidate</th>
			<th>Molecule Name</th>
			<th>Regulatory Status</th>
            <th>Similarity (T<sub>C</sub>)</th>
			</tr>
			</thead>
            <tr>
            <td><i> The UNIPROT id for the target protein sequence that is homologous to the query protein.</td></i>
            <td><i> The DrugBank id for the target homolog protein sequence. The query protein can be a target of multiple drugs in DrugBank.</td></i>
            <td><i> The percentage of query sequence covered by the alignment with target homolog. Only >70% are selected.</i></td>
            <td><i> Starting coordinates for the alignment, as per the query sequence index.</i></td>
            <td><i> Ending coordinates for the alignment, as per the query sequence index.</i></td>
            <td><i> Name of the 1&deg;Candidate (Molecues found while searching in the complete dataset).</td></i>
			<td><i> Regulatory status and category of the 1&deg; Candidate.</td></i>
            <td><i> The DrugBank id for the 2&deg; Candidate that is similar in structure to the 1&deg;Candidate.</td></i>
            <td><i> Name of the 2&deg;Candidate (found while exploring the 2D structural space of 1&deg;Candidate in approved drugs dataset).</td></i>
			<td><i> Regulatory status and category of the 2&deg;Candidate.</td></i>
            <td><i> 2D structural similarity index, Tanimoto Co-efficient*(T<sub>C</sub>), obtained by comparing 1&deg;Candidate and 2&deg;Candidate is reported.</td></i>
			</tr>
		</table>
            <tfoot><p style="text-align: right">*T<sub>C</sub> ranges from 0 to 1. Values > 0.7 are selected to ensure that highly similar 2&deg;Candidates are reported.<br></tfoot>
	</div>
        <div style="text-align: center"><p><i>NOTE: NOD Users are encouraged to use the <a href="#">clickable links</a> provided in the table to access further details about the compound or the protein.</i></b></p></div>
    <div class="container section-fg">
    
			<table id="resDisplay">
                <thead>
                <tr><strong>"Query protein: sp|Q32ZE1|POLG_ZIK	"</strong> <a href="mode2_matches.tbl" class="btn-special" style="margin-left:90%">Download Table</a><br></tr>
                <tr></tr><tr>
                    <th>S.No</th>
                    <th>Target homolog</th>
                    <th>Query Coverage</th>
                    <th>Alignment Start</th>
                    <th>Alignment End</th>
                    <th>1&deg;Candidate</th>
                    <th>Molecule Name (1&deg;)</th>
                    <th>Regulatory Status (1&deg;)</th>
                    <th>2&deg;Candidate</th>
                    <th>Molecule Name (2&deg;)</th>
                    <th>Regulatory Status (2&deg;)</th>
                    <th>Similarity (T<sub>C</sub>)</th>
                </thead>
                </tr>
<tr><td> 1 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB00811"> DB00811 </a></td><td> Ribavirin </td><td> approved </td><td> <a href="https://www.drugbank.ca/drugs/DB00811"> DB00811 </a></td><td> Ribavirin </td><td> approved </td><td> 1.0 </td></tr></tr><tr><td> 2 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB00118"> DB00118 </a></td><td> Ademetionine </td><td> approved; investigational; nutraceutical </td><td> 0.98 </td></tr></tr><tr><td> 3 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB00131"> DB00131 </a></td><td> Adenosine phosphate </td><td> approved; investigational; nutraceutical </td><td> 0.83 </td></tr></tr><tr><td> 4 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB00157"> DB00157 </a></td><td> NADH </td><td> approved; nutraceutical </td><td> 0.72 </td></tr></tr><tr><td> 5 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB00194"> DB00194 </a></td><td> Vidarabine </td><td> approved; investigational </td><td> 0.88 </td></tr></tr><tr><td> 6 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB00242"> DB00242 </a></td><td> Cladribine </td><td> approved; investigational </td><td> 0.77 </td></tr></tr><tr><td> 7 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB00631"> DB00631 </a></td><td> Clofarabine </td><td> approved; investigational </td><td> 0.74 </td></tr></tr><tr><td> 8 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB00640"> DB00640 </a></td><td> Adenosine </td><td> approved; investigational </td><td> 0.88 </td></tr></tr><tr><td> 9 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB01073"> DB01073 </a></td><td> Fludarabine </td><td> approved </td><td> 0.83 </td></tr></tr><tr><td> 10 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB01280"> DB01280 </a></td><td> Nelarabine </td><td> approved; investigational </td><td> 0.73 </td></tr></tr><tr><td> 11 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB06213"> DB06213 </a></td><td> Regadenoson </td><td> approved; investigational </td><td> 0.73 </td></tr></tr><tr><td> 12 </td><td><a href="https://www.uniprot.org/uniprot/P12823"> P12823 </a></td><td> 98.98 </td><td> 2 </td><td> 3386 </td><td><a href="https://www.drugbank.ca/drugs/DB01752"> DB01752 </a></td><td> S-adenosyl-L-homocysteine </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB13156"> DB13156 </a></td><td> Inosine pranobex </td><td> approved </td><td> 0.72 </td></tr></tr><tr><td> 13 </td><td><a href="https://www.uniprot.org/uniprot/P27915"> P27915 </a></td><td> 99.03 </td><td> 2 </td><td> 3388 </td><td><a href="https://www.drugbank.ca/drugs/DB04473"> DB04473 </a></td><td> alpha-L-fucose </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB04173"> DB04173 </a></td><td> Fructose </td><td> approved; experimental </td><td> 0.7 </td></tr></tr><tr><td> 14 </td><td><a href="https://www.uniprot.org/uniprot/P27915"> P27915 </a></td><td> 99.03 </td><td> 2 </td><td> 3388 </td><td><a href="https://www.drugbank.ca/drugs/DB04473"> DB04473 </a></td><td> alpha-L-fucose </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB04465"> DB04465 </a></td><td> Lactose </td><td> approved; experimental; investigational </td><td> 0.8 </td></tr></tr><tr><td> 15 </td><td><a href="https://www.uniprot.org/uniprot/P27915"> P27915 </a></td><td> 99.03 </td><td> 2 </td><td> 3388 </td><td><a href="https://www.drugbank.ca/drugs/DB04473"> DB04473 </a></td><td> alpha-L-fucose </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB11602"> DB11602 </a></td><td> Hydroxyethyl cellulose </td><td> approved </td><td> 0.76 </td></tr></tr><tr><td> 16 </td><td><a href="https://www.uniprot.org/uniprot/P27915"> P27915 </a></td><td> 99.03 </td><td> 2 </td><td> 3388 </td><td><a href="https://www.drugbank.ca/drugs/DB04473"> DB04473 </a></td><td> alpha-L-fucose </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB12767"> DB12767 </a></td><td> Gaxilose </td><td> approved; investigational </td><td> 0.77 </td></tr></tr><tr><td> 17 </td><td><a href="https://www.uniprot.org/uniprot/P27915"> P27915 </a></td><td> 99.03 </td><td> 2 </td><td> 3388 </td><td><a href="https://www.drugbank.ca/drugs/DB04473"> DB04473 </a></td><td> alpha-L-fucose </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB12942"> DB12942 </a></td><td> Lactitol </td><td> approved; investigational </td><td> 0.83 </td></tr></tr><tr><td> 18 </td><td><a href="https://www.uniprot.org/uniprot/P27915"> P27915 </a></td><td> 99.03 </td><td> 2 </td><td> 3388 </td><td><a href="https://www.drugbank.ca/drugs/DB04473"> DB04473 </a></td><td> alpha-L-fucose </td><td> experimental </td><td> <a href="https://www.drugbank.ca/drugs/DB15617"> DB15617 </a></td><td> Ferric derisomaltose </td><td> approved </td><td> 0.82 </td></tr></tr></table></div>
<div style="text-align:left; padding:10px; color:#913A1E;"><p><b><u>DISCLAIMER</u></b>: The drugs displayed in this table are derived from homology based similarity searches against the DrugBank database.<br>
These are predictive results and are meant to help researchers in the field of drug repurposing.<br>
Therefore, Team NOD advice its users to <b>NOT</b> consume any drug without proper consulation with their general practitioner.</i></b></p></div>			
            <!-- Table Section ENDED -->
	</div>
</div>
			<!--  Main JS File --
			<script src="webpages/assets/js/main.js"></script>
	</body>
</html>

